Home / Stockholms Medicinska Biobank / The COVID-19 Immunity study

Collection

The COVID-19 Immunity study

Description: The COMMUNITY pandemic surveillance cohort was initiated in April 2020 and comprises 2149 healthcare workers and 118 COVID-19 patients. Blood samples are collected every four months. Serological and cellular immune responses are continuously mapped to demography, vaccination(s) and prior infection. qPCR screening programs, including viral sequencing and culturing, are conducted during time points with high viral transmission and in response to the threat of emerging variants of concern (VOC).
Acronym:
COMMUNITY
Biobank:
Stockholms Medicinska Biobank
Local collection ID (within the biobank):
N/A

General information

Collection size:
10.000 - 100.000 (as of 2022-05-17)
Type:
Disease specific Hospital Sample
Data:
Biological samples Medical records
Start date of sampling:
2020-04-01
Ethical approval number:
2020-01653

Donor information

Number of donors:
1000 - 10.000
Samples from deceased (autopsy):
no
Samples from minors (<18 years old):
no
Inclusion criteria: COVID-19 patients admitted to Danderyd hospital. Inclusion criterion was COVID-19 diagnosis based on reverse-transcriptase polymerase chain reaction viral RNA detection of nasopharyngeal or oropharyngeal swabs or clinical presentation. Healthcare workers at Danderyd hospital.

Sample information

Collection contact information
Collection head: Charlotte Thålin
Contact person: Charlotte Thålin
charlotte.thalin@ki.se
Biobank contact information
Stockholms Medicinska Biobank
Registration number at IVO: 914
biobankstockholm@regionstockholm.se